NovoCure (NVCR) Other Accumulated Expenses (2014 - 2018)

NovoCure has disclosed Other Accumulated Expenses across 5 years of filings, most recently posting $32000.0 for Q4 2018.

• Other Accumulated Expenses for Q4 2018 came in at $32000.0, down 77.78% year-over-year; the trailing twelve-month figure through Dec 2018 was $32000.0 (down 77.78% YoY), and the FY2018 annual result was $32000.0, down 77.78% from the prior year.
• Other Accumulated Expenses came in at $32000.0 for Q4 2018 at NovoCure, down from $144000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $712000.0 in Q4 2015 to a low of $32000.0 in Q4 2018.
• The 5-year median for Other Accumulated Expenses is $97000.0 (2014), against an average of $212200.0.
• Across the five-year window, Other Accumulated Expenses jumped 634.02% in 2015 and tumbled 89.33% in 2016, its largest moves.
• NovoCure's Other Accumulated Expenses stood at $97000.0 in 2014, then surged by 634.02% to $712000.0 in 2015, then sank by 89.33% to $76000.0 in 2016, then jumped by 89.47% to $144000.0 in 2017, then tumbled by 77.78% to $32000.0 in 2018.
• The last three Other Accumulated Expenses figures came in at $32000.0 (Q4 2018), $144000.0 (Q4 2017), and $76000.0 (Q4 2016), per Business Quant data.